Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Unknown 3Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, T-Cell, Peripheral 1Lymphoma, Follicular 1Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 139Rituximab 115Etoposide 77Vincristine 75Doxorubicin 62Cytarabine 61Dexamethasone 58Prednisone 55fludarabine 52Methotrexate 46N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 42Lenalidomide 37Gemcitabine 35Radiotherapy 29Melphalan 27pegaspargase 22Prednisolone 22Ifosfamide 22fludarabine phosphate 20Busulfan 20Cisplatin 19Bendamustine Hydrochloride 19Asparaginase 18Peripheral Blood Stem Cell Transplantation 17ibrutinib 16Decitabine 16Carmustine 16Mercaptopurine 15Filgrastim 15Oxaliplatin 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Transplantation, Autologous × Lymphoid × Clear all
NCT04489264 2020-12-04

The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

Peking University

Unknown
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03681938 2018-09-24

Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?

Institut Paoli-Calmettes

Unknown
183 enrolled
Lymphoid

Lymphoma, B-Cell

NCT00435955 2007-02-16

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Azienda Ospedaliera San Giovanni Battista

Phase 3 Unknown
240 enrolled
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡